Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001746282-18-000001
Filing Date
2018-07-16
Accepted
2018-07-16 16:19:10
Documents
2
Period of Report
2018-07-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1520
2 POA poacalias.txt EX-24 3196
  Complete submission text file 0001746282-18-000001.txt   6097
Mailing Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202
Business Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202 410-522-8707
Cerecor Inc. (Issuer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CERECOR INC. 400 EAST PRATT STREET, SUITE 606 BALTIMORE MD 21202
Business Address
Calias Pericles (Reporting) CIK: 0001746282 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37590 | Film No.: 18954639